scholarly article | Q13442814 |
P2093 | author name string | S Murasawa | |
M Kanasaki | |||
H Matsubara | |||
Y Nio | |||
M Inada | |||
P2860 | cites work | Side-to-side slippage of myocytes participates in ventricular wall remodeling acutely after myocardial infarction in rats | Q68840738 |
Role of calcium and protein kinase C in ANP secretion by cultured rat cardiocytes | Q69038355 | ||
Importance of venodilatation in prevention of left ventricular dilatation after chronic large myocardial infarction in rats: a comparison of captopril and hydralazine | Q69483211 | ||
Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction | Q70056002 | ||
ANG II receptors, c-myc, and c-jun in myocytes after myocardial infarction and ventricular failure | Q70620780 | ||
Selective activation of cardiac angiotensinogen gene expression in post-infarction ventricular remodeling in the rat | Q70661939 | ||
Regulation of angiotensin II receptors on ventricular myocytes after myocardial infarction in rats | Q70721092 | ||
Angiotensin II is mitogenic in neonatal rat cardiac fibroblasts | Q70721116 | ||
Regulatory elements that mediate expression of the gene for the angiotensin II type 1a receptor for the rat | Q72661527 | ||
Two promoters of different strengths control the transcription of the mouse alpha-amylase gene Amy-1a in the parotid gland and the liver | Q72700850 | ||
Early dilation of the infarcted segment in acute transmural myocardial infarction: Role of infarct expansion in acute left ventricular enlargement | Q72818174 | ||
Rat angiotensin II (type 1A) receptor mRNA regulation and subtype expression in myocardial growth and hypertrophy | Q72873652 | ||
Changes of atrial natriuretic peptide and its messenger RNA with development and regression of cardiac hypertrophy in renovascular hypertensive rats | Q28329890 | ||
Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro | Q28570955 | ||
Molecular characterization of angiotensin II--induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype | Q28581981 | ||
Rat angiotensin II receptor: cDNA sequence and regulation of the gene expression | Q28645991 | ||
Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors | Q28646037 | ||
Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition | Q28646038 | ||
Expression of AT2 receptors in the developing rat fetus | Q34198676 | ||
Noncoordinate regulation of alpha-1 adrenoreceptor coupling and reexpression of alpha skeletal actin in myocardial infarction-induced left ventricular failure in rats | Q34262927 | ||
Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators | Q34539986 | ||
Augmented expression of atrial natriuretic polypeptide gene in ventricle of human failing heart | Q34564865 | ||
Wall stress and patterns of hypertrophy in the human left ventricle | Q35194096 | ||
Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. Effects on coronary resistance, contractility, and relaxation | Q35817405 | ||
Cardiac actions of angiotensin II: Role of an intracardiac renin-angiotensin system | Q35994833 | ||
Experimental myocardial infarction in the rat: qualitative and quantitative changes during pathologic evolution | Q36058597 | ||
Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system | Q37087344 | ||
Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications | Q37850831 | ||
Shaker-related potassium channel, Kv1.4, mRNA regulation in cultured rat heart myocytes and differential expression of Kv1.4 and Kv1.5 genes in myocardial development and hypertrophy | Q40305219 | ||
Differential gene expression and regulation of angiotensin II receptor subtypes in rat cardiac fibroblasts and cardiomyocytes in culture | Q40335639 | ||
Angiotensin II receptors and angiotensin II receptor antagonists. | Q40846126 | ||
Transforming growth factor beta-1 in acute myocardial infarction in rats | Q41790607 | ||
Increased ANF secretion after volume expansion is preserved in rats with heart failure | Q42141197 | ||
Angiotensin II type-1 receptor subtype cDNAs: differential tissue expression and hormonal regulation | Q42146327 | ||
Identification of angiotensin II receptor subtypes | Q42191856 | ||
Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure | Q43691056 | ||
Changes in performance of the surviving myocardium after left ventricular infarction in rats | Q43894205 | ||
Left ventricular failure induced by myocardial infarction. I. Myocyte hypertrophy | Q44817805 | ||
Identification of functional angiotensin II receptors on rat cardiac fibroblasts | Q46184530 | ||
The transcription of a mammalian voltage-gated potassium channel is regulated by cAMP in a cell-specific manner. | Q48087578 | ||
Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor | Q48225244 | ||
Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor | Q48225253 | ||
Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD123177 (AII-2). | Q48865577 | ||
Changes in expression of angiotensin receptor subtypes in the rat aorta during development. | Q52048484 | ||
Global cardiac remodeling after acute myocardial infarction: a study in the rat model | Q67289461 | ||
Regional cardiac dilatation after acute myocardial infarction: recognition by two-dimensional echocardiography | Q67463498 | ||
Remodeling of the rat right and left ventricles in experimental hypertension | Q67676009 | ||
DNA synthesis in the non-infarcted cardiac interstitium after left coronary artery ligation in the rat: Effects of captopril | Q67876140 | ||
Two distinct pathways in the down-regulation of type-1 angiotension II receptor gene in rat glomerular mesangial cells | Q68144947 | ||
Stimulation of rat atrial natriuretic peptide (rANP) synthesis by triiodothyronine and thyroxine (T4): T4 as a prohormone in synthesizing rANP | Q68408394 | ||
Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats | Q68425427 | ||
Identification and characterization of angiotensin II receptor subtypes in rabbit ventricular myocardium | Q68629226 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | myocardial infarction | Q12152 |
P304 | page(s) | 46-54 | |
P577 | publication date | 1995-01-01 | |
P1433 | published in | Journal of Clinical Investigation | Q3186904 |
P1476 | title | Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction | |
P478 | volume | 95 |
Q61443913 | A Series of Analogues to the ATR Prototype Antagonist C38 Allow Fine Tuning of the Previously Reported Antagonist Binding Mode |
Q48667990 | A new transgenic rat model overexpressing the angiotensin II type 2 receptor provides evidence for inhibition of cell proliferation in the outer adrenal cortex |
Q30421609 | A nonpeptide angiotensin II type 2 receptor agonist does not attenuate postmyocardial infarction left ventricular remodeling in mice |
Q34405412 | ACE inhibition in aortic stenosis: dangerous medicine or golden opportunity? |
Q38005936 | ARB and cardioprotection |
Q37531017 | AT(2) receptor and tissue injury: therapeutic implications |
Q43800030 | AT(2) receptor-mediated vasodilation in the heart: effect of myocardial infarction |
Q44959320 | AT1 receptor blockade limits myocardial injury and upregulates AT2 receptors during reperfused myocardial infarction |
Q45143633 | AT2 receptor and apoptosis during AT1 receptor blockade in reperfused myocardial infarction in the rat. |
Q77937510 | AT2 receptor stimulation induces generation of ceramides in PC12W cells |
Q37274124 | AT2 receptors: functional relevance in cardiovascular disease. |
Q22010261 | Analysis of functional domains of angiotensin II type 2 receptor involved in apoptosis |
Q35045801 | Angiotensin AT2 receptors: cardiovascular hope or hype? |
Q40791969 | Angiotensin II AT(2) receptors inhibit growth responses in proximal tubule cells |
Q48317328 | Angiotensin II Type 2 Receptor Deficiency Exacerbates Heart Failure and Reduces Survival After Acute Myocardial Infarction in Mice |
Q44318888 | Angiotensin II activates NADPH oxidase in isolated rat hearts subjected to ischaemia-reperfusion. |
Q30304121 | Angiotensin II and nitric oxide: a question of balance |
Q43968024 | Angiotensin II binding and extracellular matrix remodelling in a rat model of myocardial infarction |
Q77687808 | Angiotensin II stimulates both aldosterone secretion and DNA synthesis via type 1 but not type 2 receptors in bovine adrenocortical cells |
Q26748814 | Angiotensin II type 1 receptor antagonists in animal models of vascular, cardiac, metabolic and renal disease |
Q73832450 | Angiotensin II type 1 receptor expression in human pancreatic cancer and growth inhibition by angiotensin II type 1 receptor antagonist |
Q43586674 | Angiotensin II type 1 receptor regulation and differential trophic effects on rat cardiac myofibroblasts after acute myocardial infarction |
Q37557554 | Angiotensin II type 2 receptor correlates with therapeutic effects of losartan in rats with adjuvant-induced arthritis |
Q52954250 | Angiotensin II type 2 receptor gene polymorphism and cardiovascular phenotypes: the GLAECO and GLAOLD studies. |
Q37340136 | Angiotensin II type 2 receptors have a major somatodendritic distribution in vasopressin-containing neurons in the mouse hypothalamic paraventricular nucleus |
Q44618349 | Angiotensin Subtype 1 Receptor (AT1) Blockade Improves Vasorelaxation in Heart Failure by Up-Regulation of Endothelial Nitric-Oxide Synthase via Activation of the AT2Receptor |
Q73246467 | Angiotensin and bradykinin peptides in rats with myocardial infarction |
Q34268762 | Angiotensin and its AT2 receptor: new insights into an old system |
Q34825028 | Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers: evidence for and against the combination in the treatment of hypertension and proteinuria. |
Q43574343 | Angiotensin receptor in the heart of Bothrops jararaca snake |
Q24324656 | Angiotensin type 2 receptor in resistance arteries of type 2 diabetic hypertensive patients |
Q45947812 | Angiotensin-(1-7) synergizes with colony-stimulating factors in hematopoietic recovery. |
Q52524194 | Aortic medial necrosis with or without thrombosis in rabbits treated with Russell's viper venom and angiotensin II. |
Q42078470 | Apoptosis after reperfused myocardial infarction: Role of angiotensin II. |
Q35838481 | Are angiotensin receptor blockers neuroprotective? |
Q42759909 | Association between angiotensin II Type 2 receptor gene A/C3123 polymorphism and high-density lipoprotein cholesterol with hypertension in asymptomatic women |
Q24303396 | Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice |
Q34273052 | Cardiac receptor physiology and its application to clinical imaging: present and future |
Q28505671 | Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects |
Q48835664 | Cardiovascular ATIP (Angiotensin receptor type 2 interacting protein) expression in mouse development |
Q37595599 | Cardiovascular effects of losartan and its relevant clinical application |
Q44904373 | Challenges in improving prognosis and therapy: the Ongoing Telmisartan Alone and in Combination with Ramipril Global End point Trial programme |
Q37357707 | Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure. |
Q35073388 | Clinical trials evaluating angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the setting of acute myocardial infarction |
Q44506230 | Comparison of cardioprotective effects using ramipril and DanShen for the treatment of acute myocardial infarction in rats |
Q44230612 | Comparison of the antagonistic effects of different angiotensin II receptor blockers in human coronary arteries |
Q38156167 | Contribution of the Local RAS to Hematopoietic Function: A Novel Therapeutic Target |
Q44618161 | Dietary salt intake modulates progression of antithymocyte serum nephritis through alteration of glomerular angiotensin II receptor expression |
Q43648754 | Differential effects of angiotensin AT1 and AT2 receptors on the expression, translation and function of the Na+-H+ exchanger and Na+-HCO3- symporter in the rat heart after myocardial infarction |
Q50732895 | Differential effects of olmesartan and ramipril on inflammatory response after myocardial infarction in rats. |
Q54788553 | Differential response of cardiac fibroblasts from young adult and senescent rats to ANG II. |
Q35876449 | Dual blockade of the renin angiotensin system in diabetic and nondiabetic kidney disease |
Q35782663 | Early expression of all the components of the renin-angiotensin-system in human development |
Q47928468 | Effect of angiotensin II type 2 receptor blockade on mitogen activated protein kinases during myocardial ischemia-reperfusion |
Q54523618 | Effect of ramipril and losartan on collagen expression in right and left heart after myocardial infarction. |
Q43518213 | Effect of the angiotensin II type 2-receptor gene (+1675 G/A) on left ventricular structure in humans |
Q74137886 | Effects of acute and chronic angiotensin receptor blockade on myocardial vascular blood volume and perfusion in a pig model of coronary microembolization |
Q37365932 | Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors |
Q48364415 | Effects of exercise training on brain-derived neurotrophic factor in skeletal muscle and heart of rats post myocardial infarction |
Q42993543 | Efficient transcription of the human angiotensin II type 2 receptor gene requires intronic sequence elements |
Q36817896 | Endoplasmic reticulum stress increases AT1R mRNA expression via TIA-1-dependent mechanism |
Q39737596 | Evidence for the importance of angiotensin II type 1 receptor in ischemia-induced angiogenesis |
Q71807548 | Expression of Renin-Angiotensin System Components in the Heart, Kidneys, and Lungs of Rats With Experimental Heart Failure |
Q30898615 | Expression of angiotensin AT(1) and AT(2) receptors in adult rat cardiomyocytes after myocardial infarction. A single-cell reverse transcriptase-polymerase chain reaction study |
Q43964476 | Expression of angiotensin II type 1 (AT(1)) receptor in the rostral ventrolateral medulla in rats |
Q48393465 | Expression of angiotensin type 1 and 2 receptors in brain after transient middle cerebral artery occlusion in rats |
Q24563508 | Expression of the AT2 receptor developmentally programs extracellular signal-regulated kinase activity and influences fetal vascular growth |
Q36675350 | Functionalized dendrimer-based delivery of angiotensin type 1 receptor siRNA for preserving cardiac function following infarction. |
Q39097850 | Gene Therapy With Angiotensin-(1-9) Preserves Left Ventricular Systolic Function After Myocardial Infarction |
Q28307466 | Genomic organization and polymorphism of human angiotensin II type 2 receptor: no evidence for its gene mutation in two families of human premature ovarian failure syndrome |
Q36842513 | Hypercholesterolaemia exacerbates ventricular remodelling after myocardial infarction in the rat: role of angiotensin II type 1 receptors |
Q38290362 | Identification of a Negative Cis-regulatory Element and Trans-acting Protein That Inhibit Transcription of the Angiotensin II Type 1a Receptor Gene |
Q73782374 | Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation |
Q47276862 | Infarct size reduction by AT1-receptor blockade through a signal cascade of AT2-receptor activation, bradykinin and prostaglandins in pigs |
Q47771363 | Inhibition of the expression of the gene for the angiotensin AT1 receptor by angiotensin II in the rat adrenal gland |
Q38477579 | Interaction network analysis revealed biomarkers in myocardial infarction |
Q38346150 | Interferon regulatory factor-1 up-regulates angiotensin II type 2 receptor and induces apoptosis |
Q36241932 | International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected]. |
Q35581620 | Is angiotensin II a direct mediator of left ventricular hypertrophy? Time for another look |
Q34766179 | Long-term effects of early overnutrition in the heart of male adult rats: role of the renin-angiotensin system |
Q34170513 | Measurement of the renin-angiotensin system in heart failure |
Q30306044 | Mechanism of action of angiotensin-receptor blocking agents |
Q41647752 | Metabolic responses of extracellular matrix in tissue repair |
Q90191397 | Mice lacking angiotensin type 2 receptor exhibit a sex-specific attenuation of insulin sensitivity |
Q36748599 | Moderate cardiac-selective overexpression of angiotensin II type 2 receptor protects cardiac functions from ischaemic injury |
Q41084357 | Molecular biology of angiotensin receptors and their role in human cardiovascular disease |
Q46551320 | Myocardial expression, signaling, and function of GPR22: a protective role for an orphan G protein-coupled receptor |
Q39795853 | Myocardial ischemia induces differential regulation of KATP channel gene expression in rat hearts |
Q41391367 | Myofibroblasts and local angiotensin II in rat cardiac tissue repair |
Q74506097 | N- and C-terminal structure-activity study of angiotensin II on the angiotensin AT2 receptor |
Q41284840 | Neuroendocrine activation after myocardial infarction: causes and consequences |
Q34963358 | Nitric oxide and cardioprotection during ischemia-reperfusion |
Q35090355 | Nitric oxide and cardiovascular protection |
Q30306043 | Novel actions of angiotensin II via its renal type-2 (AT(2)) receptor |
Q52184810 | Ontogeny and regulation of cardiac angiotensin types 1 and 2 receptors during fetal life in sheep. |
Q49053455 | Opposite regulation of brain angiotensin type 1 and type 2 receptors in cold-induced hypertension |
Q34982563 | Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling. |
Q33832734 | Pertussis toxin up-regulates angiotensin type 1 receptors through Toll-like receptor 4-mediated Rac activation. |
Q33405633 | Pharmacodynamic stimulation of thrombogenesis by angiotensin (1-7) in recurrent ovarian cancer patients receiving gemcitabine and platinum-based chemotherapy |
Q48389554 | Pituitary-dependent expression of the testicular angiotensin II receptor and its subtypes in rats |
Q36216855 | Prevention of remodeling in congestive heart failure due to myocardial infarction by blockade of the renin-angiotensin system |
Q34297736 | Protection against ischemia: a physiological function of the renin-angiotensin system |
Q77921912 | Reciprocal change in angiotensinogen mRNA expression in rat myocardium and liver after myocardial infarction |
Q51432835 | Role of AT(1) receptors and autonomic nervous system in mediating acute pressor responses to ANG II in anesthetized mice. |
Q42837409 | Role of Angiontensin Receptors on Remodeling Perivascular Nerves |
Q28571720 | Role of the angiotensin II AT2 receptor in inflammation and oxidative stress: opposing effects in lean and obese Zucker rats |
Q38693277 | Salt, Angiotensin II, Superoxide, and Endothelial Function |
Q47962829 | Sciatic nerve transection evokes lasting up-regulation of angiotensin AT2 and AT1 receptor mRNA in adult rat dorsal root ganglia and sciatic nerves |
Q46540831 | Selective type 1 angiotensin II receptor blockade attenuates oxidative stress and regulates angiotensin II receptors in the canine failing heart |
Q36400573 | Small-molecule AT2 receptor agonists |
Q36691346 | Structure of the Rat V1a Vasopressin Receptor Gene and Characterization of Its Promoter Region and Complete cDNA Sequence of the 3′-End |
Q33680652 | The AT2 receptor: fact, fancy and fantasy |
Q44183049 | The ERK pathway regulates Na(+)-HCO(3)(-) cotransport activity in adult rat cardiomyocytes. |
Q42448400 | The Expression of MTUS1/ATIP and Its Major Isoforms, ATIP1 and ATIP3, in Human Prostate Cancer |
Q34117578 | The Renin-Angiotensin system mediates the effects of stretch on conduction velocity, connexin43 expression, and redistribution in intact ventricle |
Q33792965 | The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer |
Q36404036 | The angiotensin II type 2 (AT2) receptor promotes axonal regeneration in the optic nerve of adult rats |
Q38332834 | The increase in angiotensin type-2 receptor mRNA level by glutamate stimulation in cultured rat cortical cells |
Q40853213 | The interaction of nitric oxide, bradykinin, and the angiotensin II type 2 receptor: lessons learned from transgenic mice |
Q43907226 | The involvement of AT(2)-receptor in the antithrombotic effect of losartan in renal hypertensive rats. |
Q41592393 | The kallikrein-kinin system in post-myocardial infarction cardiac remodeling |
Q37622572 | The past, present and future of angiotensin II type 2 receptor stimulation |
Q42451386 | The receptors and role of angiotensin II in knee joint blood flow regulation and role of nitric oxide in modulation of their function |
Q33217815 | The renin-angiotensin system: current data |
Q34522515 | The role of the renin-angiotensin system in the development of cardiovascular disease |
Q28346501 | Transcriptional and translational regulation of calpain in the rat heart after myocardial infarction--effects of AT(1) and AT(2) receptor antagonists and ACE inhibitor |
Q39185363 | Transforming growth factor type beta 1 increases the expression of angiotensin II receptor type 2 by a SMAD- and p38 MAPK-dependent mechanism in skeletal muscle. |
Q48842101 | Transient upregulation of the AT2 receptor mRNA level after global ischemia in the rat brain |
Q44594372 | Upregulation of Angiotensin II Type 2 Receptor and Limitation of Myocardial Stunning by Angiotensin II Type 1 Receptor Blockers during Reperfused Myocardial Infarction in the Rat |
Q35908017 | Valsartan Upregulates Kir2.1 in Rats Suffering from Myocardial Infarction via Casein Kinase 2. |
Q37897570 | Valsartan plus hydrochlorothiazide: a review of its use since its introduction |
Search more.